Sionna Therapeutics (SION) Total Liabilities (2024 - 2026)

Sionna Therapeutics has disclosed Total Liabilities across 3 years of filings, most recently posting $16.8 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $16.8 million, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.8 million (down 6.0% YoY), and the FY2025 annual result was $19.1 million, changed 0.12% from the prior year.
• Total Liabilities came in at $16.8 million for Q1 2026 at Sionna Therapeutics, down from $19.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $148.5 million in Q3 2024 to a low of $15.6 million in Q2 2025.
• The 3-year median for Total Liabilities is $19.1 million (2024), against an average of $57.2 million.
• Peak annual rise in Total Liabilities reached 0.12% in 2025, while the deepest fall reached 88.32% in 2025.
• Sionna Therapeutics' Total Liabilities stood at $19.1 million in 2024, then advanced by 0.12% to $19.1 million in 2025, then decreased by 11.97% to $16.8 million in 2026.
• The last three Total Liabilities figures came in at $16.8 million (Q1 2026), $19.1 million (Q4 2025), and $17.6 million (Q3 2025), per Business Quant data.